AbbVie, Inc.AbbVie, Inc.AbbVie, Inc.

AbbVie, Inc.

Không có giao dịch

Chứng khoán nợ doanh nghiệp

Dưới đây là danh sách trái phiếu AbbVie, Inc., được sắp xếp theo lợi suất đến ngày đáo hạn. Trong giai đoạn thị trường biến động, nhà đầu tư thường lựa chọn trái phiếu doanh nghiệp nhờ tính ổn định cao hơn. Hãy xem xét giá, lợi suất và các số liệu khác để tìm ra khoản đầu tư đáng tin cậy.
YTM %
Khối lượng
Giá %
Phiếu giảm giá %
Ngày đáo hạn
Giá trị dư nợ
Giá trị khuôn mặt
Giá trị mệnh giá tối thiểu
Bên phát hành
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7.00%26 K76.04%4.750%2045-03-1553.51 M USD1,000.00 USD2,000.00 USD
Allergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6.40%12 K83.25%4.850%2044-06-1565.23 M USD1,000.00 USD2,000.00 USD
Allergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6.38%124 K81.98%4.625%2042-10-0167.49 M USD1,000.00 USD2,000.00 USD
Actavis, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5.79%250 K91.22%4.550%2035-03-15107.65 M USD1,000.00 USD2,000.00 USD
Allergan Funding SCS
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.57%1.76 M98.86%5.500%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.50%10.73 M98.57%5.400%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.49%26 K90.47%3.200%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5.49%12.67 M101.56%5.600%2055-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.46%658 K92.36%4.875%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.45%519 K92.01%4.750%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5.44%18.94 M84.09%4.250%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
5.43%087.96%4.450%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
5.41%091.50%4.700%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.36%2.1 M94.17%4.850%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.32%5.96 M100.30%5.350%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.30%30 K92.23%4.625%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US00287YAM12AbbVie Inc. 4.4% 06-NOV-2042
5.27%090.34%4.400%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.04%3.21 M90.25%4.050%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
4.74%096.43%4.300%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
4.68%098.67%4.500%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4.65%5.06 M99.28%4.550%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4.64%3.87 M104.12%5.200%2035-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4.52%4.56 M103.52%5.050%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.10%1.96 M103.88%4.950%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
4.02%096.43%2.625%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EUR
Allergan Funding SCS
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
3.95%099.82%3.200%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
3.95%12.24 M103.44%4.875%2030-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
3.90%6.98 M97.55%3.200%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3.85%737 K102.74%4.800%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
3.82%094.83%2.125%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EUR
Allergan Funding SCS
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3.79%1.78 M101.16%4.250%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3.75%13.05 M101.06%4.800%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
3.72%762 K101.80%4.650%2028-03-151.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3.66%2.07 M99.46%2.950%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3.16%0126.76%4.750%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
3.13%0128.71%4.850%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3.13%0121.31%4.250%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
2.92%091.24%1.250%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
2.60%098.75%2.125%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
2.59%098.55%2.125%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.57%0123.74%4.550%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
2.52%0100.27%2.625%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
2.37%097.24%0.750%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
−5.92%098.80%2.950%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
4.400%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.